<DOC>
	<DOC>NCT00641329</DOC>
	<brief_summary>The purpose of this study is to determine if CLONICEL (clonidine HCl sustained release) is a safe and effective add-on to psychostimulant therapy in children and adolescents with attention deficit hyperactivity disorder (ADHD).</brief_summary>
	<brief_title>CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Clonidine</mesh_term>
	<criteria>Age 617 years, inclusive Diagnosis of ADHD Currently on a stable psychostimulant regimen for ADHD Lack of adequate response to stable psychostimulant regimen Ability to swallow tablets Clinically significant illnesses or abnormalities upon evaluation Conduct Disorder Intolerance to clonidine History of seizures or syncope</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>ADHD</keyword>
	<keyword>ADD</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Attention Deficit</keyword>
	<keyword>Clonidine</keyword>
	<keyword>CLONICEL</keyword>
	<keyword>Addrenex</keyword>
</DOC>